Susan Ezzone, MS, RN | Authors

39350 9 MILE RD


Commentary (Ezzone)-Graft-Versus-Host Disease: A Complex Long-Term Side Effect of Hematopoietic Stem Cell

October 01, 2008

Prophylaxis and management of graft-versus-host disease (GVHD) following a related or unrelated allogeneic hematopoietic stem cell transplant (HSCT) is very complex. The review article written by Barton-Burke and colleagues discusses all of the major components of the clinical manifestations, prophylaxis, and treatment of GVHD.